tiprankstipranks
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Financial Statements

28 Followers

Bone Biologics Financial Overview

Bone Biologics's market cap is currently ―. The company's EPS TTM is $-22.629; its P/E ratio is -0.05; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 940.85K$ -1.16M$ -1.92M$ -1.77M$ 2.58M
EBITDA$ 940.85K$ -1.16M$ -1.92M$ -1.77M$ 2.58M
Net Income Common Stockholders$ -900.00K$ -1.55M$ -1.92M$ -1.77M$ 2.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.20M$ 3.00M$ 4.50M$ 7.00M$ 6.19M
Total Assets$ 3.84M$ 3.74M$ 4.98M$ 7.62M$ 6.78M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.20M$ -3.00M$ -4.50M$ -7.00M$ -6.19M
Total Liabilities$ 164.63K$ 831.40K$ 1.18M$ 1.93M$ 4.01M
Stockholders Equity$ 3.67M$ 2.91M$ 3.79M$ 5.73M$ 2.77M
Cash Flow-
Free Cash Flow$ -1.30M$ -2.10M$ -2.50M$ -3.66M$ -1.34M
Operating Cash Flow$ -1.30M$ -2.10M$ -2.50M$ -3.66M$ -1.34M
Investing Cash Flow-----
Financing Cash Flow$ 1.50M$ 592.00K-$ 4.45M-
Currency in USD

Bone Biologics Earnings and Revenue History

Bone Biologics Debt to Assets

Bone Biologics Cash Flow

Bone Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis